Back

Determinant factors of plasma fibroblast growth factor 23 levels in patients with heart failure patients with reduced ejection fraction

25 May 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Chronic Heart Failure – Diagnostic Methods Biomarkers HFA Premium Access Heart Failure 2019

About the speaker

Photo
Professor Damien Gruson

Cliniques Saint-Luc UCL, Brussels (Belgium)

22 More presentations in this session

Presentation thumbnail
Functional capacity and body composition in subjects with heart failure and COPD
Presentation thumbnail
Evaluation of body composition and endothelial dysfunction in heart failure and chronic obstructive pulmonary disease subjects
Presentation thumbnail
Performance of an implanted cardiac device heart failure risk predictor, in a real-world tertiary heart failure clinic
Doctor B. Li (Basildon, GB)
Abstract Slides
Presentation thumbnail
Rate pressure product and severely impaired systolic function in heart failure patients
Presentation thumbnail
Improving diagnostic awareness of amyloidosis among cardiologists: effectiveness of online education
Doctor J. Spyropoulos (Purchase, US)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Chronic Heart Failure – Diagnostic Methods

The Event

Event poster

Heart Failure 2019

25 May - 28 May 2019
You may be interested in
thumbnail
Congress Presentation
The role of a multimarker panel in the diagnosis and prognosis of patients with acute heart failure
thumbnail
Congress Presentation
Novel biomarkers reveal distinct biological phenotypes in heart failure with preserved vs reduced ejection fraction
thumbnail
Congress Presentation
Growth differentiation factor 15 and absorption loss as new biomarkers of heart failure decompensation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources